Evidence map›Paper›PMID 25002527›Full record

ArticleMolecular and cellular biology2014

Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition.

Peng Ye, Junsei Mimura, Tomomi Okada, Hideyo Sato, Tao Liu, Atsushi Maruyama, Chikara Ohyama, Ken Itoh

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 139 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 1 synthesis or guideline pooled it, 198 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Dissecting Complex Interactions Between Ferroptosis and the Proteasome.bioRxiv : the preprint server for biology · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Emerging Roles of Ferroptosis in Skin Pathophysiology.The Journal of investigative dermatology · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Targeting ferroptosis for precision medicine in cervical cancer.Apoptosis : an international journal on programmed cell death · 2025
    Review
  19. Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Peng YeDepartment of Stress Response Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Junsei MimuraDepartment of Stress Response Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan jmimura@cc.hirosaki-u.ac.jp.
Tomomi OkadaDepartment of Food and Applied Life Sciences, Faculty of Agriculture, Yamagata University, Tsuruoka, Yamagata, Japan.
Hideyo SatoDepartment of Food and Applied Life Sciences, Faculty of Agriculture, Yamagata University, Tsuruoka, Yamagata, Japan.
Tao LiuDepartment of Stress Response Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Atsushi MaruyamaDepartment of Stress Response Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Chikara OhyamaDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Ken ItohDepartment of Stress Response Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Hirosaki University · JPYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ubiquitin-proteasome pathway degrades ubiquitinated proteins to remove damaged or misfolded protein and thus plays an important role in the maintenance of many important cellular processes. Because the pathway is also crucial for tumor cell growth and survival, proteasome inhibition by specific inhibitors exhibits potent antitumor effects in many cancer cells. xCT, a subunit of the cystine antiporter system xc (-), plays an important role in cellular cysteine and glutathione homeostasis. Several recent reports have revealed that xCT is involved in cancer cell survival; however, it was unknown whether xCT affects the cytotoxic effects of proteasome inhibitors. In this study, we found that two stress-inducible transcription factors, Nrf2 and ATF4, were upregulated by proteasome inhibition and cooperatively enhance human xCT gene expression upon proteasome inhibition. In addition, we demonstrated that the knockdown of xCT by small interfering RNA (siRNA) or pharmacological inhibition of xCT by sulfasalazine (SASP) or (S)-4-carboxyphenylglycine (CPG) significantly increased the sensitivity of T24 cells to proteasome inhibition. These results suggest that the simultaneous inhibition of both the proteasome and xCT could have therapeutic benefits in the treatment of bladder tumors.

Indexed as

Activating Transcription Factor 4Amino Acid Transport System y+Antineoplastic AgentsBoronic AcidsBortezomibCell Line, TumorCysteineGene Expression Regulation, NeoplasticGene Knockdown TechniquesGlutathioneGlycineHEK293 CellsHeLa CellsHumansLeupeptinsNF-E2-Related Factor 2Activating Transcription Factor 4Amino Acid Transport System y+Antineoplastic AgentsATF4 protein, humanbenzyloxycarbonylleucyl-leucyl-leucine aldehydeBoronic AcidsBortezomibcarboxyphenylglycinecarfilzomibCysteineepoxomicinGlutathioneGlycineLeupeptinsNFE2L2 protein, humanNF-E2-Related Factor 2OligopeptidesProteasome Endopeptidase ComplexPyrazinesRNA, Small InterferingSLC7A11 protein, humanSulfasalazine

Identifiers

PMID25002527
PMCPMC4135628
OpenAlexW2165129832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.